BBAI stock jumps 16% into BigBear.ai share-vote week — what to watch next
7 February 2026
2 mins read

BBAI stock jumps 16% into BigBear.ai share-vote week — what to watch next

New York, Feb 7, 2026, 08:52 EST — Market is shut.

Shares of BigBear.ai Holdings, Inc (NYSE: BBAI) surged 15.7% Friday, ending the session at $4.72. That rally hauled the small-cap AI and defense player straight back into the spotlight for traders eyeing next week’s action. 1

This comes into play now because BigBear.ai is approaching a key shareholder vote that could nearly double its authorized share count—potentially smoothing the path to raising capital, funding acquisitions, or handing out equity awards, though not without diluting current shareholders. The company’s rescheduled special meeting lands on Feb. 18, with online ballots accepted up to late Feb. 17. 2

Derivatives traders piled in as stocks bounced. Friday saw a spike in options trades, with the put/call ratio at just 0.19, according to GuruFocus — that’s a level pointing to a wave of call buying over puts. 3

Coming off a rough session, the stock settled at $4.08 on Thursday—a 9.3% drop—with about 72 million shares changing hands, according to Yahoo Finance data. 4

The broader view remains unclear. Shares of BigBear.ai have slid roughly 36% in the past month, erasing a large chunk of gains from earlier, data from Simply Wall St. show. 5

Some of that spotlight has landed back on deals BigBear.ai flagged in January. The company announced on Jan. 21 it had acquired certain CargoSeer technologies—software touted to help customs officials identify high-risk cargo using computer vision and machine learning. CEO Kevin McAleenan said the move fits “directly” with BigBear.ai’s push into customs agency tech. 6

One week on, AD Ports Group in Abu Dhabi announced that its digital subsidiary, Maqta Technologies, has struck a partnership with BigBear.ai’s local unit to look into AI solutions for customs and logistics. Captain Mohamed Juma Al Shamisi, the group’s CEO, called the deal a “significant step” toward advancing digital trade and customs with artificial intelligence. 7

Right now, it’s all about the share count. BigBear.ai’s proxy lays out a request: bump up the number of authorized common shares to 1 billion from the current 500 million. McAleenan pushed back on concerns, saying this isn’t a move to “immediately issue and sell” those additional shares. 8

The mechanics work both ways here. Should shareholders sign off on the increase, investors will be on alert for any moves by the company to raise capital through equity—potentially putting pressure on shares if dilution becomes a concern. A failed vote, on the other hand, could box BigBear.ai in, limiting its options for funding growth, something market watchers have pointed out as a real risk around this proposal. 9

BigBear.ai tends to ride the waves of bigger AI and data-analytics stocks, only the moves get exaggerated—thanks to its smaller scale and a calendar packed with catalysts. The sharp move on Friday didn’t bring much clarity.

Investors are eyeing the Feb. 18 reconvened special meeting as the next major catalyst. What happens there—and any details on financing that emerge after—will shape sentiment as U.S. markets come back online and through the following week. 10

Stock Market Today

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
New York, Feb 7, 2026, 09:35 EST — Market closed. Roivant Sciences Ltd shares leapt on Friday after the company reported positive mid-stage results for its immune-modulating drug brepocitinib in a rare skin disease, and paired the readout with its quarterly financial update. The Nasdaq-listed stock closed up 22.4% at $25.82, leaving traders to gauge whether the move has legs when U.S. markets reopen on Monday, Feb. 9. It matters because Roivant is trying to turn a late-stage pipeline into approvals, and the market has been quick to reward biotechs that can show clean efficacy in controlled trials. The company
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
AMD stock jumps 8% in chip rebound — what investors are watching before Monday

AMD stock jumps 8% in chip rebound — what investors are watching before Monday

7 February 2026
AMD shares jumped 8.2% to $208.44 Friday, trading on heavy volume as chip stocks rebounded and the Dow closed above 50,000 for the first time. The Philadelphia Semiconductor Index rose 5.7% after Amazon’s AI spending plans lifted sector estimates. Nvidia’s CEO cited surging AI chip demand. AMD’s rally followed a weak revenue outlook earlier in the week.
Strategy (MSTR) stock price whipsaws after $12.4 billion loss as bitcoin steadies — what to watch next week
Previous Story

Strategy (MSTR) stock price whipsaws after $12.4 billion loss as bitcoin steadies — what to watch next week

Alphabet stock drops for a fourth straight day as AI spending jitters linger
Next Story

Alphabet stock drops for a fourth straight day as AI spending jitters linger

Go toTop